Gordon Sussman Clinical Research, Inc.
Toronto, Ontario, Canada
Allergist in Toronto, Ontario
240 Duncan Mill Rd Suite 703, North York, ON M3B 3S6
About Gordon Sussman Clinical Research, Inc.
"Dr. Sussman is an Allergist and Clinical Immunologist practicing in the North York area. Our clinic has been treating patients in Toronto and the surrounding area for over 30 years. Dr. Sussman’s expertise in investigator initiated clinical trials and his insight into patient care have lead to numerous developments in allergy treatments and discoveries."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
DBV Technologies
7
Aimmune Therapeutics, Inc.
5
Amgen
2
CSL Behring
2
Green Cross Corporation
2
Regeneron Pharmaceuticals
2
Shire
2
ASLAN Pharmaceuticals
1
Genentech, Inc.
1
Kedrion S.p.A.
1
Clinical Trials at Gordon Sussman Clinical Research, Inc.
During the past decade, Gordon Sussman Clinical Research, Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on
average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
2011-09-01
2013-07-01
Completed
45
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
2012-11-12
2014-08-27
Completed
45
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
2012-08-01
2014-07-01
Completed
221
Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children
2013-09-01
2016-09-01
Completed
171
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
2014-11-01
2020-12-22
Completed
198
Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
2016-03-03
2017-04-13
Completed
125
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
2015-12-22
2018-07-02
Completed
555
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
2015-12-01
2017-08-18
Completed
356
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gordon Sussman Clinical Research, Inc." #1 sponsor was "DBV Technologies" with 7 trials, followed by "Aimmune Therapeutics, Inc." with 5 trials
sponsored, "Amgen" with 2 trials sponsored, "CSL Behring" with 2 trials sponsored and "Green Cross Corporation"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gordon Sussman Clinical Research, Inc."
#1 collaborator was "Atlantic Research Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Gordon Sussman Clinical Research, Inc.
According to Clinical.Site data, the most researched conditions in "Gordon Sussman Clinical Research, Inc." are
"Peanut Allergy" (10 trials), "Atopic Dermatitis" (2 trials), "Hereditary Angioedema" (2 trials), "Hereditary Angioedema (HAE)" (2 trials) and "Agammaglobulinemia" (1 trials). Many other conditions were trialed in "Gordon Sussman Clinical Research, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Gordon Sussman Clinical Research, Inc.
Most popular intervention types in "Gordon Sussman Clinical Research, Inc." are "Biological" (16 trials), "Drug" (10 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "AR101" (4 trials), "Viaskin Peanut 250 mcg" (3 trials), "CSL312" (2 trials) and "Viaskin Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Gordon Sussman Clinical Research, Inc.
The vast majority of trials in "Gordon Sussman Clinical Research, Inc." are
25 trials for "All" genders.
Clinical Trials Status at Gordon Sussman Clinical Research, Inc.
Currently, there are NaN active trials in "Gordon Sussman Clinical Research, Inc.".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 17 completed trials in Gordon Sussman Clinical Research, Inc.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gordon Sussman Clinical Research, Inc., 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".